Tianjin Development (00882.HK) announced its unaudited financial results of the subsidiary Tianjin Lisheng Pharmaceutical Co., Ltd. ("Lisheng Pharmaceutical") for the six months ended June 30, 2022. During the period, the company achieved a total operating income of approximately - DayDayNews hotcomm

Tianjin Development (00882.HK) announced its unaudited financial results of the subsidiary Tianjin Lisheng Pharmaceutical Co., Ltd. ("Lisheng Pharmaceutical") for the six months ended June 30, 2022. During the period, the company achieved a total operating income of approximately

Tianjin Development (00882.HK) released interim results of Lisheng Pharmaceuticals (002393.SZ), with net profit attributable to shareholders of approximately RMB 71.9539 million, an increase of 17.47% year-on-year
According to statistics from each market, in June this year, the average increase of 335 gold stock targets in the entire market reached 9.33%, setting a new high this year. During the same period, the Shanghai Composite Index rose 6.66%, and the ChiNext Index rose 16.86%. - DayDayNews hotcomm

According to statistics from each market, in June this year, the average increase of 335 gold stock targets in the entire market reached 9.33%, setting a new high this year. During the same period, the Shanghai Composite Index rose 6.66%, and the ChiNext Index rose 16.86%.

"Track stocks" make efforts! In June, the average increase of securities companies' gold stocks reached 9.33%, and all the 50 securities companies' gold stock portfolios made positive returns in a single month